Summit Partners Public Asset Management »

Cidara Therapeutics shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $106M 478k 220.89
2025-09-30 $12M 130k 95.76

More positions owned by Summit Partners Public Asset Management

Sandisk Corp Put Option (SNDK)
Insmed Com Par $.01 (INSM)
Mongodb Cl A Put Option (MDB)
Spotify Technology S A SHS (SPOT)
NVIDIA Corporation Call Option (NVDA)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A (SEI)
Ge Vernova (GEV)
Credo Technology Group Holdi Ordinary Shares Put Option (CRDO)
Tower Semiconductor Shs New (TSEM)
Ionis Pharmaceuticals Put Option (IONS)
Genedx Holdings Corp Com Cl A (WGS)
Cidara Therapeutics Com New (CDTX)
Jfrog Ord Shs (FROG)
Natera (NTRA)

View all positions for Summit Partners Public Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BVF
BlackRock
UBS Group
Darwin Global Management
Paradigm Biocapital Advisors
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics